Efficacy and safety of gabapentin versus placebo to prevent the incidence of PostHerpetic Neuralgia: a double-blinded clinical trial
Phase of Trial: Phase III
Latest Information Update: 19 Jan 2017
Price : $35 *
At a glance
- Drugs Gabapentin (Primary) ; Valaciclovir
- Indications Herpes zoster; Postherpetic neuralgia
- Focus Therapeutic Use
- Acronyms PHN
- 14 Jan 2017 Trial design published at Trials.
- 16 Nov 2015 Status changed from recruiting to completed, as reported by ISRCTN: Current Controlled Trials record.
- 09 May 2013 New trial record